drugset

drugset / Trial / NCT00134303

Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity

NCT00134303 ↗

Phase 4 Completed 65 enrolled University Hospital, Ghent Merck Sharp & Dohme LLC · collab

RandomizedSingle-groupDouble-blindTreatment

Summary

This is a comparison of metformin versus placebo in NASH patients receiving bariatric surgery for obesity.

Timeline

Start: 2005-06
Primary completion: 2006-03-31
Completion: 2006-03-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Metformin	Small molecule	850 mg	Oral

Indications